Ray Co., Ltd. (228670.KQ)

KRW 6250.0

(-2.5%)

Total Debt Summary of Ray Co., Ltd.

Ray Co., Ltd.'s latest annual total debt in 2023 was 86.67 Billion KRW , up 5.34% from previous year.
Ray Co., Ltd.'s latest quarterly total debt in 2024 Q2 was 101.52 Billion KRW , up 2.84% from previous quarter.
Ray Co., Ltd. reported annual total debt of 82.28 Billion KRW in 2022, up 40.66% from previous year.
Ray Co., Ltd. reported annual total debt of 58.5 Billion KRW in 2021, up 420.59% from previous year.
Ray Co., Ltd. reported quarterly total debt of 98.71 Billion KRW for 2024 Q1, up 13.89% from previous quarter.
Ray Co., Ltd. reported quarterly total debt of 81.33 Billion KRW for 2023 Q3, up 6.43% from previous quarter.

Annual Total Debt Chart of Ray Co., Ltd. (2023 - 2017)

Historical Annual Total Debt of Ray Co., Ltd. (2023 - 2017)

Year	Total Debt	Total Debt Growth
2023	86.67 Billion KRW	5.34%
2022	82.28 Billion KRW	40.66%
2021	58.5 Billion KRW	420.59%
2020	11.23 Billion KRW	135.27%
2019	4.77 Billion KRW	40.48%
2018	3.4 Billion KRW	-30.95%
2017	4.92 Billion KRW	0.0%

Year	Total Debt	Total Debt Growth
2024 Q2	101.52 Billion KRW	2.84%
2024 Q1	98.71 Billion KRW	13.89%
2023 Q3	81.33 Billion KRW	6.43%
2023 Q4	86.67 Billion KRW	6.57%
2023 FY	86.67 Billion KRW	5.34%
2023 Q2	76.42 Billion KRW	-2.04%
2023 Q1	78.01 Billion KRW	-5.19%
2022 Q3	78.89 Billion KRW	38.84%
2022 Q4	82.28 Billion KRW	4.29%
2022 Q2	56.82 Billion KRW	-0.48%
2022 Q1	57.1 Billion KRW	-2.39%
2021 Q4	58.5 Billion KRW	34.79%
2021 Q3	43.4 Billion KRW	0.0%

Peer Total Debt Comparison of Ray Co., Ltd.

Name	Total Debt	Total Debt Difference
Osang Healthcare Co.,Ltd	697.79 Million KRW	-12321.818%
InBody Co.,Ltd	6.08 Billion KRW	-1325.57%
Curexo Inc.	2.05 Billion KRW	-4109.008%
Seegene, Inc.	141.76 Billion KRW	38.857%
i-SENS, Inc.	143.79 Billion KRW	39.719%
Gencurix Inc.	17.95 Billion KRW	-382.759%
Sugentech Inc.	15.3 Billion KRW	-466.396%
L&C Bio Co., Ltd	82.13 Billion KRW	-5.533%